Perspectives on the Design of Clinical Trials Combining Transarterial Chemoembolization and Molecular Targeted Therapy

Publisher： Karger

E-ISSN： 1664-5553|1|3-4|168-176

ISSN： 2235-1795

Source： Liver Cancer, Vol.1, Iss.3-4, 2012-11, pp. : 168-176

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Trials of Combined Molecular Targeted Therapy and Locoregional Therapy in Hepatocellular Carcinoma: Past, Present, and Future

By  

Liver Cancer, Vol. 3, Iss. 1, 2014-02 ,pp. : 9-17

Karger

Access to resources Recommend Favorite

Molecular targeted therapy for advanced hepatocellular carcinoma: current status and future perspectives

By Shen Ying-Chun   Hsu Chiun   Cheng Ann-Lii  

Journal of Gastroenterology, Vol. 45, Iss. 8, 2010-08 ,pp. : 794-807

Springer Publishing Company

Access to resources Recommend Favorite

Outcome of supraselective transarterial chemoembolization in patients with hepatocellular carcinoma

By Heinzow Hauke Sebastian   Meister Tobias   Nass Dominik   Kööhler Michael   Spieker Tilmann   Wolters Heiner   Domschke Wolfram   Domagk Dirk  

Scandinavian Journal of Gastroenterology, Vol. 46, Iss. 2, 2011-02 ,pp. : 201-210

Informa Healthcare

Access to resources Recommend Favorite

Signaling Pathway and Molecular-Targeted Therapy for Hepatocellular Carcinoma

By  

Digestive Diseases, Vol. 29, Iss. 3, 2011-08 ,pp. : 289-302

Karger

Access to resources Recommend Favorite

Molecular Targeted Therapy for Hepatocellular Carcinoma: Bench to Bedside

By  

Digestive Diseases, Vol. 29, Iss. 3, 2011-08 ,pp. : 273-277

Karger

Access to resources Recommend Favorite